dyskinesias And NotAndrew Evans
List of bibliographic references
Number of relevant bibliographic references: 21.Ident. | Authors (with country if any) | Title |
---|---|---|
000246 | Thomas Wichmann [États-Unis] ; Mahlon R. Delong [États-Unis] ; Jorge Guridi [Espagne] ; Jose A. Obeso [Espagne] | Milestones in research on the pathophysiology of Parkinson's disease |
000407 | Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
000638 | Iria Cabo L Pez [Espagne] ; Pedro J. García Ruiz [Espagne] ; Silvia Vázquez Fernández Del Pozo [Espagne] ; Vicenta Sánchez Bernardos [Espagne] | Motor complications in Parkinson's disease: Ten year follow‐up study |
000937 | M. M. Wickremaratchi [Royaume-Uni] ; Y. Ben-Shlomo [Royaume-Uni] ; H. R. Morris [Royaume-Uni] | The effect of onset age on the clinical features of Parkinson’s disease |
000A11 | Giovanni Fabbrini [Italie] ; Giovanni Defazio [Italie] ; Carlo Colosimo [Italie] ; Antonio Suppa [Italie] ; Maria Bloise [Italie] ; Alfredo Berardelli [Italie] | Onset and spread of dyskinesias and motor symptoms in Parkinson's disease |
000B01 | C. Marin [Espagne] ; E. Aguilar [Espagne] ; G. Mengod [Espagne] ; R. Cortés [Espagne] ; J. A. Obeso [Espagne] | Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats |
000C36 | Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis] | Treatment of levodopa‐induced motor complications |
000C50 | Anthony H. V. Schapira [Royaume-Uni] | The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease |
000D31 | Maryka Quik [États-Unis] ; Kathryn O'Leary [États-Unis] ; Caroline M. Tanner [États-Unis] | Nicotine and Parkinson's disease: Implications for therapy |
000F33 | Charlene Hoffman Snyder [États-Unis] ; Charles H. Adler [États-Unis] | The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms |
000F51 | J. Herzog [Allemagne] ; M. Pinsker [Allemagne] ; M. Wasner [Allemagne] ; F. Steigerwald [Allemagne] ; S. Wailke [Allemagne] ; G. Deuschl [Allemagne] ; J. Volkmann [Allemagne] | Stimulation of subthalamic fibre tracts reduces dyskinesias in STN‐DBS |
000F70 | Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
001309 | P. Odin [Allemagne] ; C. Oehlwein [Allemagne] ; A. Storch [Allemagne] ; U. Polzer [Allemagne] ; G. Werner [Allemagne] ; R. Renner [Allemagne] ; M. Shing [Allemagne] ; A. Ludolph [Allemagne] ; P. Schüler [Allemagne] | Efficacy and safety of high‐dose cabergoline in Parkinson's disease |
001349 | Paolo Mazzone [Italie] ; Fabrizio Stocchi [Italie] ; Salvatore Galati [Italie] ; Angelo Insola [Italie] ; Maria Grazia Altibrandi [Italie] ; Nicola Modugno [Italie] ; Domenicantonio Tropepi [Italie] ; Livia Brusa [Italie] ; Alessandro Stefani [Italie] | Bilateral Implantation of Centromedian‐Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease |
001427 | Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis] | Role of surgery in the treatment of motor complications |
001450 | Cheryl Waters [États-Unis] | Other pharmacological treatments for motor complications and dyskinesias |
001499 | M. Péchevis [France] ; C. E. Clarke [Royaume-Uni] ; P. Vieregge [Allemagne] ; B. Khoshnood [France] ; C. Deschaseaux-Voinet [France] ; G. Berdeaux [France] ; M. Ziegler [France] | Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study |
001612 | Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
001899 | Karen Stergaard [Danemark] ; Niels Sunde [Danemark] ; Erik Dupont [Danemark] | Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations |
001A69 | J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis] | Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature |
001C39 | Anette Schrag [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Dyskinesias and motor fluctuations in Parkinson's disease |
This area was generated with Dilib version V0.6.23. |